0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Constipation Treatment Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-3V16813
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Chronic Constipation Treatment Drugs Market Research Report 2024
BUY CHAPTERS

Global Chronic Constipation Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-3V16813
Report
September 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chronic Constipation Treatment Drugs Market

The global market for Chronic Constipation Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Chronic Constipation Treatment Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Chronic Constipation Treatment Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Chronic Constipation Treatment Drugs include Pfizer, Ardelyx, Norgine, Takeda Pharmaceuticals, Ironwood Pharmaceuticals, Synergy Pharmaceuticals, Salix Pharmaceuticals, Shire Pharmaceuticals, Allergan, Renexxion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Constipation Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Constipation Treatment Drugs.
The Chronic Constipation Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Constipation Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Constipation Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chronic Constipation Treatment Drugs Market Report

Report Metric Details
Report Name Chronic Constipation Treatment Drugs Market
Segment by Type
  • Serotonin-4 (5-Ht4) Receptor Agonist
  • Guanylate Cyclase-C Agonist
  • Laxatives
  • Stimulants
  • Others
Segment by Application
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Ardelyx, Norgine, Takeda Pharmaceuticals, Ironwood Pharmaceuticals, Synergy Pharmaceuticals, Salix Pharmaceuticals, Shire Pharmaceuticals, Allergan, Renexxion, Sucampo Pharmaceuticals, Shionogi, Teva Pharmaceuticals, RedHill Biopharma, Ferring Pharmaceuticals, Theravance Biopharma, Progenity Inc., Synthetic Biologics, Progenics Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Chronic Constipation Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Chronic Constipation Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Chronic Constipation Treatment Drugs Market report?

Ans: The main players in the Chronic Constipation Treatment Drugs Market are Pfizer, Ardelyx, Norgine, Takeda Pharmaceuticals, Ironwood Pharmaceuticals, Synergy Pharmaceuticals, Salix Pharmaceuticals, Shire Pharmaceuticals, Allergan, Renexxion, Sucampo Pharmaceuticals, Shionogi, Teva Pharmaceuticals, RedHill Biopharma, Ferring Pharmaceuticals, Theravance Biopharma, Progenity Inc., Synthetic Biologics, Progenics Pharmaceuticals

What are the Application segmentation covered in the Chronic Constipation Treatment Drugs Market report?

Ans: The Applications covered in the Chronic Constipation Treatment Drugs Market report are Hospitals, Homecare, Specialty Clinics, Others

What are the Type segmentation covered in the Chronic Constipation Treatment Drugs Market report?

Ans: The Types covered in the Chronic Constipation Treatment Drugs Market report are Serotonin-4 (5-Ht4) Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others

1 Chronic Constipation Treatment Drugs Market Overview
1.1 Product Definition
1.2 Chronic Constipation Treatment Drugs by Type
1.2.1 Global Chronic Constipation Treatment Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Serotonin-4 (5-Ht4) Receptor Agonist
1.2.3 Guanylate Cyclase-C Agonist
1.2.4 Laxatives
1.2.5 Stimulants
1.2.6 Others
1.3 Chronic Constipation Treatment Drugs by Application
1.3.1 Global Chronic Constipation Treatment Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Chronic Constipation Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Chronic Constipation Treatment Drugs Revenue 2020-2031
1.4.2 Global Chronic Constipation Treatment Drugs Sales 2020-2031
1.4.3 Global Chronic Constipation Treatment Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Chronic Constipation Treatment Drugs Market Competition by Manufacturers
2.1 Global Chronic Constipation Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Chronic Constipation Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Chronic Constipation Treatment Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Chronic Constipation Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Constipation Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Constipation Treatment Drugs, Product Type & Application
2.7 Global Key Manufacturers of Chronic Constipation Treatment Drugs, Date of Enter into This Industry
2.8 Global Chronic Constipation Treatment Drugs Market Competitive Situation and Trends
2.8.1 Global Chronic Constipation Treatment Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Chronic Constipation Treatment Drugs Players Market Share by Revenue
2.8.3 Global Chronic Constipation Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chronic Constipation Treatment Drugs Market Scenario by Region
3.1 Global Chronic Constipation Treatment Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Chronic Constipation Treatment Drugs Sales by Region: 2020-2031
3.2.1 Global Chronic Constipation Treatment Drugs Sales by Region: 2020-2025
3.2.2 Global Chronic Constipation Treatment Drugs Sales by Region: 2026-2031
3.3 Global Chronic Constipation Treatment Drugs Revenue by Region: 2020-2031
3.3.1 Global Chronic Constipation Treatment Drugs Revenue by Region: 2020-2025
3.3.2 Global Chronic Constipation Treatment Drugs Revenue by Region: 2026-2031
3.4 North America Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Chronic Constipation Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Chronic Constipation Treatment Drugs Sales by Country (2020-2031)
3.4.3 North America Chronic Constipation Treatment Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Chronic Constipation Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Chronic Constipation Treatment Drugs Sales by Country (2020-2031)
3.5.3 Europe Chronic Constipation Treatment Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Constipation Treatment Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Chronic Constipation Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Chronic Constipation Treatment Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Chronic Constipation Treatment Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Chronic Constipation Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Chronic Constipation Treatment Drugs Sales by Country (2020-2031)
3.7.3 Latin America Chronic Constipation Treatment Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Constipation Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Chronic Constipation Treatment Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Chronic Constipation Treatment Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Constipation Treatment Drugs Sales by Type (2020-2031)
4.1.1 Global Chronic Constipation Treatment Drugs Sales by Type (2020-2025)
4.1.2 Global Chronic Constipation Treatment Drugs Sales by Type (2026-2031)
4.1.3 Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2020-2031)
4.2 Global Chronic Constipation Treatment Drugs Revenue by Type (2020-2031)
4.2.1 Global Chronic Constipation Treatment Drugs Revenue by Type (2020-2025)
4.2.2 Global Chronic Constipation Treatment Drugs Revenue by Type (2026-2031)
4.2.3 Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Chronic Constipation Treatment Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Chronic Constipation Treatment Drugs Sales by Application (2020-2031)
5.1.1 Global Chronic Constipation Treatment Drugs Sales by Application (2020-2025)
5.1.2 Global Chronic Constipation Treatment Drugs Sales by Application (2026-2031)
5.1.3 Global Chronic Constipation Treatment Drugs Sales Market Share by Application (2020-2031)
5.2 Global Chronic Constipation Treatment Drugs Revenue by Application (2020-2031)
5.2.1 Global Chronic Constipation Treatment Drugs Revenue by Application (2020-2025)
5.2.2 Global Chronic Constipation Treatment Drugs Revenue by Application (2026-2031)
5.2.3 Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Chronic Constipation Treatment Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Chronic Constipation Treatment Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Ardelyx
6.2.1 Ardelyx Company Information
6.2.2 Ardelyx Description and Business Overview
6.2.3 Ardelyx Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ardelyx Chronic Constipation Treatment Drugs Product Portfolio
6.2.5 Ardelyx Recent Developments/Updates
6.3 Norgine
6.3.1 Norgine Company Information
6.3.2 Norgine Description and Business Overview
6.3.3 Norgine Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Norgine Chronic Constipation Treatment Drugs Product Portfolio
6.3.5 Norgine Recent Developments/Updates
6.4 Takeda Pharmaceuticals
6.4.1 Takeda Pharmaceuticals Company Information
6.4.2 Takeda Pharmaceuticals Description and Business Overview
6.4.3 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.4.5 Takeda Pharmaceuticals Recent Developments/Updates
6.5 Ironwood Pharmaceuticals
6.5.1 Ironwood Pharmaceuticals Company Information
6.5.2 Ironwood Pharmaceuticals Description and Business Overview
6.5.3 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.5.5 Ironwood Pharmaceuticals Recent Developments/Updates
6.6 Synergy Pharmaceuticals
6.6.1 Synergy Pharmaceuticals Company Information
6.6.2 Synergy Pharmaceuticals Description and Business Overview
6.6.3 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.6.5 Synergy Pharmaceuticals Recent Developments/Updates
6.7 Salix Pharmaceuticals
6.7.1 Salix Pharmaceuticals Company Information
6.7.2 Salix Pharmaceuticals Description and Business Overview
6.7.3 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.7.5 Salix Pharmaceuticals Recent Developments/Updates
6.8 Shire Pharmaceuticals
6.8.1 Shire Pharmaceuticals Company Information
6.8.2 Shire Pharmaceuticals Description and Business Overview
6.8.3 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.8.5 Shire Pharmaceuticals Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Company Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Allergan Chronic Constipation Treatment Drugs Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Renexxion
6.10.1 Renexxion Company Information
6.10.2 Renexxion Description and Business Overview
6.10.3 Renexxion Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Renexxion Chronic Constipation Treatment Drugs Product Portfolio
6.10.5 Renexxion Recent Developments/Updates
6.11 Sucampo Pharmaceuticals
6.11.1 Sucampo Pharmaceuticals Company Information
6.11.2 Sucampo Pharmaceuticals Description and Business Overview
6.11.3 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.11.5 Sucampo Pharmaceuticals Recent Developments/Updates
6.12 Shionogi
6.12.1 Shionogi Company Information
6.12.2 Shionogi Description and Business Overview
6.12.3 Shionogi Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shionogi Chronic Constipation Treatment Drugs Product Portfolio
6.12.5 Shionogi Recent Developments/Updates
6.13 Teva Pharmaceuticals
6.13.1 Teva Pharmaceuticals Company Information
6.13.2 Teva Pharmaceuticals Description and Business Overview
6.13.3 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.13.5 Teva Pharmaceuticals Recent Developments/Updates
6.14 RedHill Biopharma
6.14.1 RedHill Biopharma Company Information
6.14.2 RedHill Biopharma Description and Business Overview
6.14.3 RedHill Biopharma Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 RedHill Biopharma Chronic Constipation Treatment Drugs Product Portfolio
6.14.5 RedHill Biopharma Recent Developments/Updates
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Company Information
6.15.2 Ferring Pharmaceuticals Description and Business Overview
6.15.3 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments/Updates
6.16 Theravance Biopharma
6.16.1 Theravance Biopharma Company Information
6.16.2 Theravance Biopharma Description and Business Overview
6.16.3 Theravance Biopharma Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Theravance Biopharma Chronic Constipation Treatment Drugs Product Portfolio
6.16.5 Theravance Biopharma Recent Developments/Updates
6.17 Progenity Inc.
6.17.1 Progenity Inc. Company Information
6.17.2 Progenity Inc. Description and Business Overview
6.17.3 Progenity Inc. Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Progenity Inc. Chronic Constipation Treatment Drugs Product Portfolio
6.17.5 Progenity Inc. Recent Developments/Updates
6.18 Synthetic Biologics
6.18.1 Synthetic Biologics Company Information
6.18.2 Synthetic Biologics Description and Business Overview
6.18.3 Synthetic Biologics Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Synthetic Biologics Chronic Constipation Treatment Drugs Product Portfolio
6.18.5 Synthetic Biologics Recent Developments/Updates
6.19 Progenics Pharmaceuticals
6.19.1 Progenics Pharmaceuticals Company Information
6.19.2 Progenics Pharmaceuticals Description and Business Overview
6.19.3 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.19.5 Progenics Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Constipation Treatment Drugs Industry Chain Analysis
7.2 Chronic Constipation Treatment Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Constipation Treatment Drugs Production Mode & Process Analysis
7.4 Chronic Constipation Treatment Drugs Sales and Marketing
7.4.1 Chronic Constipation Treatment Drugs Sales Channels
7.4.2 Chronic Constipation Treatment Drugs Distributors
7.5 Chronic Constipation Treatment Drugs Customer Analysis
8 Chronic Constipation Treatment Drugs Market Dynamics
8.1 Chronic Constipation Treatment Drugs Industry Trends
8.2 Chronic Constipation Treatment Drugs Market Drivers
8.3 Chronic Constipation Treatment Drugs Market Challenges
8.4 Chronic Constipation Treatment Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Chronic Constipation Treatment Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Chronic Constipation Treatment Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Chronic Constipation Treatment Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Chronic Constipation Treatment Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Chronic Constipation Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Chronic Constipation Treatment Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Chronic Constipation Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Chronic Constipation Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Chronic Constipation Treatment Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Chronic Constipation Treatment Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Chronic Constipation Treatment Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Chronic Constipation Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Constipation Treatment Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Chronic Constipation Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Chronic Constipation Treatment Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Chronic Constipation Treatment Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Chronic Constipation Treatment Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Chronic Constipation Treatment Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Chronic Constipation Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Chronic Constipation Treatment Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Chronic Constipation Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Chronic Constipation Treatment Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Chronic Constipation Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Chronic Constipation Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Chronic Constipation Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Chronic Constipation Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Chronic Constipation Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Chronic Constipation Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Chronic Constipation Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Chronic Constipation Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Chronic Constipation Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Chronic Constipation Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Chronic Constipation Treatment Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Chronic Constipation Treatment Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Chronic Constipation Treatment Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Chronic Constipation Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Chronic Constipation Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Chronic Constipation Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Chronic Constipation Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Chronic Constipation Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Chronic Constipation Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Chronic Constipation Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Chronic Constipation Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Chronic Constipation Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Chronic Constipation Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Chronic Constipation Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Chronic Constipation Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Chronic Constipation Treatment Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Chronic Constipation Treatment Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Chronic Constipation Treatment Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Chronic Constipation Treatment Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Chronic Constipation Treatment Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Chronic Constipation Treatment Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Chronic Constipation Treatment Drugs Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Ardelyx Company Information
 Table 76. Ardelyx Description and Business Overview
 Table 77. Ardelyx Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ardelyx Chronic Constipation Treatment Drugs Product
 Table 79. Ardelyx Recent Developments/Updates
 Table 80. Norgine Company Information
 Table 81. Norgine Description and Business Overview
 Table 82. Norgine Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Norgine Chronic Constipation Treatment Drugs Product
 Table 84. Norgine Recent Developments/Updates
 Table 85. Takeda Pharmaceuticals Company Information
 Table 86. Takeda Pharmaceuticals Description and Business Overview
 Table 87. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 89. Takeda Pharmaceuticals Recent Developments/Updates
 Table 90. Ironwood Pharmaceuticals Company Information
 Table 91. Ironwood Pharmaceuticals Description and Business Overview
 Table 92. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 94. Ironwood Pharmaceuticals Recent Developments/Updates
 Table 95. Synergy Pharmaceuticals Company Information
 Table 96. Synergy Pharmaceuticals Description and Business Overview
 Table 97. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 99. Synergy Pharmaceuticals Recent Developments/Updates
 Table 100. Salix Pharmaceuticals Company Information
 Table 101. Salix Pharmaceuticals Description and Business Overview
 Table 102. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 104. Salix Pharmaceuticals Recent Developments/Updates
 Table 105. Shire Pharmaceuticals Company Information
 Table 106. Shire Pharmaceuticals Description and Business Overview
 Table 107. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 109. Shire Pharmaceuticals Recent Developments/Updates
 Table 110. Allergan Company Information
 Table 111. Allergan Description and Business Overview
 Table 112. Allergan Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Allergan Chronic Constipation Treatment Drugs Product
 Table 114. Allergan Recent Developments/Updates
 Table 115. Renexxion Company Information
 Table 116. Renexxion Description and Business Overview
 Table 117. Renexxion Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Renexxion Chronic Constipation Treatment Drugs Product
 Table 119. Renexxion Recent Developments/Updates
 Table 120. Sucampo Pharmaceuticals Company Information
 Table 121. Sucampo Pharmaceuticals Description and Business Overview
 Table 122. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 124. Sucampo Pharmaceuticals Recent Developments/Updates
 Table 125. Shionogi Company Information
 Table 126. Shionogi Description and Business Overview
 Table 127. Shionogi Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shionogi Chronic Constipation Treatment Drugs Product
 Table 129. Shionogi Recent Developments/Updates
 Table 130. Teva Pharmaceuticals Company Information
 Table 131. Teva Pharmaceuticals Description and Business Overview
 Table 132. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 134. Teva Pharmaceuticals Recent Developments/Updates
 Table 135. RedHill Biopharma Company Information
 Table 136. RedHill Biopharma Description and Business Overview
 Table 137. RedHill Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. RedHill Biopharma Chronic Constipation Treatment Drugs Product
 Table 139. RedHill Biopharma Recent Developments/Updates
 Table 140. Ferring Pharmaceuticals Company Information
 Table 141. Ferring Pharmaceuticals Description and Business Overview
 Table 142. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 144. Ferring Pharmaceuticals Recent Developments/Updates
 Table 145. Theravance Biopharma Company Information
 Table 146. Theravance Biopharma Description and Business Overview
 Table 147. Theravance Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Theravance Biopharma Chronic Constipation Treatment Drugs Product
 Table 149. Theravance Biopharma Recent Developments/Updates
 Table 150. Progenity Inc. Company Information
 Table 151. Progenity Inc. Description and Business Overview
 Table 152. Progenity Inc. Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Progenity Inc. Chronic Constipation Treatment Drugs Product
 Table 154. Progenity Inc. Recent Developments/Updates
 Table 155. Synthetic Biologics Company Information
 Table 156. Synthetic Biologics Description and Business Overview
 Table 157. Synthetic Biologics Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Synthetic Biologics Chronic Constipation Treatment Drugs Product
 Table 159. Synthetic Biologics Recent Developments/Updates
 Table 160. Progenics Pharmaceuticals Company Information
 Table 161. Progenics Pharmaceuticals Description and Business Overview
 Table 162. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product
 Table 164. Progenics Pharmaceuticals Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Chronic Constipation Treatment Drugs Distributors List
 Table 168. Chronic Constipation Treatment Drugs Customers List
 Table 169. Chronic Constipation Treatment Drugs Market Trends
 Table 170. Chronic Constipation Treatment Drugs Market Drivers
 Table 171. Chronic Constipation Treatment Drugs Market Challenges
 Table 172. Chronic Constipation Treatment Drugs Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Chronic Constipation Treatment Drugs
 Figure 2. Global Chronic Constipation Treatment Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chronic Constipation Treatment Drugs Market Share by Type: 2024 & 2031
 Figure 4. Serotonin-4 (5-Ht4) Receptor Agonist Product Picture
 Figure 5. Guanylate Cyclase-C Agonist Product Picture
 Figure 6. Laxatives Product Picture
 Figure 7. Stimulants Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Chronic Constipation Treatment Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Chronic Constipation Treatment Drugs Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Homecare
 Figure 13. Specialty Clinics
 Figure 14. Others
 Figure 15. Global Chronic Constipation Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Chronic Constipation Treatment Drugs Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Chronic Constipation Treatment Drugs Sales (2020-2031) & (K Units)
 Figure 18. Global Chronic Constipation Treatment Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 19. Chronic Constipation Treatment Drugs Report Years Considered
 Figure 20. Chronic Constipation Treatment Drugs Sales Share by Manufacturers in 2024
 Figure 21. Global Chronic Constipation Treatment Drugs Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Chronic Constipation Treatment Drugs Players: Market Share by Revenue in Chronic Constipation Treatment Drugs in 2024
 Figure 23. Chronic Constipation Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Chronic Constipation Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Chronic Constipation Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 26. North America Chronic Constipation Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. United States Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Chronic Constipation Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 30. Europe Chronic Constipation Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Chronic Constipation Treatment Drugs Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Chronic Constipation Treatment Drugs Revenue Market Share by Region (2020-2031)
 Figure 38. China Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Chronic Constipation Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Chronic Constipation Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Chronic Constipation Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Chronic Constipation Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Chronic Constipation Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Chronic Constipation Treatment Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Chronic Constipation Treatment Drugs by Type (2020-2031)
 Figure 57. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Chronic Constipation Treatment Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Chronic Constipation Treatment Drugs by Application (2020-2031)
 Figure 60. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 61. Chronic Constipation Treatment Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS